Biologic therapy was associated with more than seven times greater odds of reaching sustained remission compared with ...

We also assess the rationale for clinical trials of IL-1 inhibitors aimed at preserving β-cell functional mass in patients with new-onset T1DM.

Patients with adult-onset Still's disease were much more likely to achieve sustained remission when they were initially ...